Susan Panozzo
Researcher
University of Arkansas for Medical Sciences
faculty
Research Areas
Is this your profile? Verify and claim your profile
Biography and Research Information
OverviewAI-generated summary
Susan Panozzo's research centers on clinical trials and long-term follow-up studies for multiple myeloma, a type of blood cancer. Her publications investigate treatment protocols, including the efficacy of various drug combinations and transplant strategies. She has examined the role of adverse cytogenetics and the impact of adding bortezomib and thalidomide to fractionated melphalan transplants. Panozzo's work also includes evaluating maintenance therapy with VRD (bortezomib, lenalidomide, dexamethasone) and analyzing the long-term outcomes of patients treated on earlier Total Therapy protocols. Her recent publications focus on the results of phase 3 clinical trials, such as Total Therapy IIIB and IV, and their extended follow-up periods, contributing to the understanding of treatment effectiveness and patient survival in multiple myeloma.
Metrics
- h-index: 6
- Publications: 30
- Citations: 421
Selected Publications
- Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols (2025) DOI
- Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma (2024) DOI
- Three years of maintenance with VRD in multiple myeloma: results of total therapy IIIB with a 15-year follow-up (2023) DOI
- Total Therapy (TT)-4: A Phase 3 Trial Comparing L-TT4 and S-TT4 and Tandem Auto Transplants in Standard Risk Multiple Myeloma (2023) DOI
Collaborators
Researchers in the database who share publications
Similar Researchers
Based on overlapping research topics